Compare CINT & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CINT | TALK |
|---|---|---|
| Founded | 1995 | 2012 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 566.6M | 656.0M |
| IPO Year | 2021 | N/A |
| Metric | CINT | TALK |
|---|---|---|
| Price | $5.00 | $4.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $6.80 | $5.90 |
| AVG Volume (30 Days) | 155.5K | ★ 1.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.00 | $24.10 |
| Revenue Next Year | $12.62 | $18.15 |
| P/E Ratio | ★ $17.94 | $155.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.98 | $2.22 |
| 52 Week High | $7.28 | $5.18 |
| Indicator | CINT | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 65.85 |
| Support Level | $4.93 | $2.52 |
| Resistance Level | $5.24 | $5.18 |
| Average True Range (ATR) | 0.19 | 0.28 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 72.41 | 74.33 |
CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.